Have we come full circle - or moved forward? The Women's Health Initiative 10 years on

Area of Science:

• Reproductive Endocrinology
• Clinical Trials
• Women's Health

Background:

• The 2002 Women's Health Initiative (WHI) trial cessation significantly impacted women's health research and clinical practice.
• Initial WHI trials focused on postmenopausal women, often asymptomatic, initiating hormone therapy (HRT) considerably past menopause.

Purpose of the Study:

• To re-evaluate the Women's Health Initiative (WHI) findings on combination hormone therapy (HRT) with a decade of hindsight.
• To clarify the benefit-risk ratio of HRT based on menopausal status, age at initiation, and symptom presentation.

Main Methods:

• Retrospective analysis of data from the Women's Health Initiative (WHI) trials.
• Integration of findings with subsequent studies and emerging research on HRT mechanisms and administration.

Main Results:

• The WHI definitively showed no treatment benefits for HRT in asymptomatic women starting therapy well after menopause.
• Accumulated data suggest HRT initiated near menopause, particularly for symptomatic women, likely offers a favorable benefit-risk ratio.

Conclusions:

• The generalization of initial WHI findings to all postmenopausal women was an oversimplification.
• Current evidence supports the judicious use of HRT initiated near menopause for specific indications, emphasizing nuanced application based on individual patient profiles.